More than 70% of users of injectable lenacapavir for HIV prevention in Uganda are men
More than 70 percent of Ugandans accessing lenacapavir, the twice-yearly HIV prevention injection, are men, with a significant proportion coming ...
Tag: PrEP
NDA clears new injectable HIV prevention drug; to be administered twice a year
The National Drug Authority (NDA) has approved Lenacapavir, a long-acting HIV prevention drug administered just twice a year, marking a ...
Uganda rolls out injectable HIV drug
The Ministry of Health has announced the first administration of Cabotegravir (Cab-LA) as part of Uganda’s expanded HIV prevention strategies. ...
Join us on this journey as we continue to be your trusted source for the bold, accurate, and authoritative news, information, and knowledge you need to stay informed, engaged, and inspired. Uganda's stories are worth telling, and UG Bulletin is here to bring them to you.
